PTGX vs. QQQ

In the year-to-date period, PTGX achieves a 22.98% return, which is significantly higher than QQQ's 1.69% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Protagonist Therapeutics Inc (PTGX) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PTGX Sharpe Ratio is 1.11, which is higher than the QQQ Sharpe Ratio of 0.62. The chart below compares the historical Sharpe Ratios of PTGX and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

PTGX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.58%.

The maximum PTGX drawdown since its inception was -85.79%, roughly equal to the maximum QQQ drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for PTGX and QQQ.

Protagonist Therapeutics Inc (PTGX) has a higher volatility of 11.42% compared to Invesco QQQ (QQQ) at 5.62%. This indicates that PTGX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.